Jing Ma

1.6k total citations
67 papers, 1.2k citations indexed

About

Jing Ma is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Immunology. According to data from OpenAlex, Jing Ma has authored 67 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 13 papers in Pulmonary and Respiratory Medicine and 12 papers in Immunology. Recurrent topics in Jing Ma's work include Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (5 papers), Cancer-related molecular mechanisms research (5 papers) and Gut microbiota and health (4 papers). Jing Ma is often cited by papers focused on Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (5 papers), Cancer-related molecular mechanisms research (5 papers) and Gut microbiota and health (4 papers). Jing Ma collaborates with scholars based in China, United States and Italy. Jing Ma's co-authors include David L. Williams, Jim Kelley, I. William Browder, Tuanzhu Ha, Race L. Kao, Fang Hua, Chuanfu Li, Xiang Gao, Fengyun Wang and Jinxin Ma and has published in prestigious journals such as Angewandte Chemie International Edition, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Jing Ma

63 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jing Ma China 18 428 306 203 163 112 67 1.2k
Yujun Shen China 22 498 1.2× 239 0.8× 157 0.8× 151 0.9× 39 0.3× 52 1.3k
Seiichi Munesue Japan 22 568 1.3× 329 1.1× 168 0.8× 215 1.3× 44 0.4× 57 1.6k
Elena Codrici Romania 18 402 0.9× 209 0.7× 146 0.7× 184 1.1× 46 0.4× 38 1.4k
Evguenia Arguiri United States 25 528 1.2× 138 0.5× 326 1.6× 184 1.1× 70 0.6× 37 1.5k
Pei‐Ling Chi Taiwan 23 561 1.3× 234 0.8× 119 0.6× 200 1.2× 53 0.5× 42 1.2k
Chao Xiao China 19 513 1.2× 145 0.5× 115 0.6× 250 1.5× 66 0.6× 37 1.1k
Tao Sun China 18 489 1.1× 198 0.6× 109 0.5× 149 0.9× 211 1.9× 67 1.1k
Renpeng Zhou China 19 679 1.6× 174 0.6× 159 0.8× 230 1.4× 63 0.6× 68 1.2k
Jingyan Han United States 23 734 1.7× 295 1.0× 181 0.9× 139 0.9× 206 1.8× 46 1.8k
Louise Dunn Australia 20 729 1.7× 145 0.5× 194 1.0× 173 1.1× 237 2.1× 44 1.7k

Countries citing papers authored by Jing Ma

Since Specialization
Citations

This map shows the geographic impact of Jing Ma's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jing Ma with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jing Ma more than expected).

Fields of papers citing papers by Jing Ma

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jing Ma. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jing Ma. The network helps show where Jing Ma may publish in the future.

Co-authorship network of co-authors of Jing Ma

This figure shows the co-authorship network connecting the top 25 collaborators of Jing Ma. A scholar is included among the top collaborators of Jing Ma based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jing Ma. Jing Ma is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ma, Jing, et al.. (2025). Design of a quinoxalinone-based AIE probe for the detection of ROS in in vitro and in vivo sepsis models. Biomaterials Science. 13(12). 3298–3306. 2 indexed citations
2.
Wu, Xu, Yaoyao Fu, Jing Ma, et al.. (2025). Blocking calcium-MYC regulatory axis inhibits early dedifferentiation of chondrocytes and contributes to cartilage regeneration. Stem Cell Research & Therapy. 16(1). 372–372. 1 indexed citations
3.
Zhao, Binyan, Hongyou Zhou, Bailing Zhou, et al.. (2025). Antimicrobial peptide DP7 alleviates dextran sulfate sodium (DSS)‐induced colitis via modifying gut microbiota and regulating intestinal barrier function. MedComm. 6(2). e70085–e70085. 2 indexed citations
4.
Huang, Jinke, et al.. (2025). Modified Gegen Qinlian Decoction Ameliorates DSS‐Induced Colitis in Mice via the Modulation of NF‐ κ B and Nrf2/HO‐1 Pathways. Mediators of Inflammation. 2025(1). 7468297–7468297. 1 indexed citations
5.
Ma, Jing, Jun Zhao, Yingna Feng, et al.. (2024). Efgartigimod versus intravenous immunoglobulin in the treatment of patients with impending myasthenic crisis. Scientific Reports. 14(1). 28394–28394. 8 indexed citations
6.
Yang, Zhihong, Hui Gao, Jing Ma, et al.. (2024). Unique urine and serum metabolomic signature in patients with excessive alcohol use: An exploratory study. Alcohol Clinical and Experimental Research. 48(8). 1519–1528. 1 indexed citations
7.
Zhang, Jing, Fei Sun, Jing Ma, et al.. (2024). Discovery and Total Synthesis of Anhydrotuberosin as a STING Antagonist for Treating Autoimmune Diseases. Angewandte Chemie International Edition. 64(1). e202407641–e202407641. 3 indexed citations
8.
Ma, Jing, Lu Ding, Wei Zhang, et al.. (2024). Licoricesaponin G2 ameliorates bleomycin-induced pulmonary fibrosis via targeting TNF-α signaling pathway and inhibiting the epithelial-mesenchymal transition. Frontiers in Pharmacology. 15. 1437231–1437231. 4 indexed citations
9.
10.
Yang, Yingying, Lu Ding, Tingting Bao, et al.. (2021). Network Pharmacology and Experimental Assessment to Explore the Pharmacological Mechanism of Qimai Feiluoping Decoction Against Pulmonary Fibrosis. Frontiers in Pharmacology. 12. 770197–770197. 17 indexed citations
11.
Sun, Qian, et al.. (2020). Effects of Astragalus Polysaccharides Nanoparticles on Cerebral Thrombosis in SD Rats. Frontiers in Bioengineering and Biotechnology. 8. 616759–616759. 7 indexed citations
12.
Wen, Qing, et al.. (2020). Diaphragm ultrasound in the diagnosis of respiratory dysfunction in patients with amyotrophic lateral sclerosis. Revue Neurologique. 177(6). 639–646. 6 indexed citations
13.
14.
Ma, Jing, et al.. (2017). Effect of combination of amlodipine and ziyin huoxue fang on hypertension patients with coronary heart disease and omentin-1, MMP-3, and TIMP-1 in blood. Biomedical Research-tokyo. 28(20). 9127–9131.
15.
Zhang, Zhongxiao, Jing Ma, Shuaishuai Liu, et al.. (2017). Fully-covered metallic stenting in an infant with tracheoesophageal fistula due to button battery ingestion. International Journal of Pediatric Otorhinolaryngology. 95. 80–83. 3 indexed citations
16.
17.
Ma, Jing, et al.. (2010). [DRD2/ANKK1 Taq IA polymorphism and early infant temperament].. PubMed. 12(2). 106–9. 1 indexed citations
18.
Hua, Fang, Jing Ma, Tuanzhu Ha, et al.. (2008). Preconditioning with a TLR2 specific ligand increases resistance to cerebral ischemia/reperfusion injury. Journal of Neuroimmunology. 199(1-2). 75–82. 85 indexed citations
19.
Herberth, Gunda, Heike Audring, Hao Wang, et al.. (2005). Differential Expression of MART-1, Tyrosinase, and SM5-1 in Primary and Metastatic Melanoma. American Journal of Dermatopathology. 27(5). 401–406. 28 indexed citations
20.
Trefzer, Uwe, Heike Audring, Gunda Herberth, et al.. (2000). SM5-1: a new monoclonal antibody which is highly sensitive and specific for melanocytic lesions. Archives of Dermatological Research. 292(12). 583–589. 33 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yujun Shen Breakdown of academic impact, for papers by Seiichi Munesue Breakdown of academic impact, for papers by Elena Codrici Breakdown of academic impact, for papers by Evguenia Arguiri Breakdown of academic impact, for papers by Pei‐Ling Chi Breakdown of academic impact, for papers by Chao Xiao Breakdown of academic impact, for papers by Tao Sun Breakdown of academic impact, for papers by Renpeng Zhou Breakdown of academic impact, for papers by Jingyan Han Breakdown of academic impact, for papers by Louise Dunn
Rankless by CCL
2026